Recombinant Human PEX7, T7-tagged

• Cat.No.: PEX7-2963H
• Product Overview: Recombinant Human PEX7 (1-323 aa) is expressed inE.Coliwith a T7 tag at N-terminus.

Specification

• Cat. No.: PEX7-2963H
• Description: This gene encodes the cytosolic receptor for the set of peroxisomal matrix enzymes targeted to the organelle by the peroxisome targeting signal 2 (PTS2). Defects in this gene cause peroxisome biogenesis disorders (PBDs), which are characterized by multiple defects in peroxisome function. There are at least 14 complementation groups for PBDs, with more than one phenotype being observed in cases falling into particular complementation groups. Although the clinical features of PBD patients vary, cells from all PBD patients exhibit a defect in the import of one or more classes of peroxisomal matrix proteins into the organelle. Defects in this gene have been associated with PBD complementation group 11 (PBD-CG11) disorders, rhizomelic chondrodysplasia punctata type 1 (RCDP1), and Refsum disease (RD).
• Source: E.Coli.
• MW: 35892 Da.
• Purity: 95%.
• Formulation: 10 mM Tris. pH 8.0. 0.1% Triton X-100.0.002% NaN3. 10mM DTT.
• Application: MS. SDS.

Gene Information

• Gene Name: PEX7 peroxisomal biogenesis factor 7 [ Homo sapiens ]
• Synonyms: PEX7; peroxisomal biogenesis factor 7;PTS2 receptor; peroxin-7; peroxisomal PTS2 receptor; peroxisomal targeting signal 2 receptor; peroxisome targeting signal 2 receptor; RP11-55K22.6; PTS2R; RCDP1; RD
• Gene ID: 5191
• mRNA Refseq: NM_000288
• Protein Refseq: NP_000279
• MIM: 601757
• UniProt ID: O00628
• Chromosome Location: 6q23.3
• Pathway: Peroxisome
• Function: peroxisome matrix targeting signal-2 binding